Loading stock data…
$65.49+0.06 (+0.09%)
CareDx, Inc.
CareDx, Inc. in the Healthcare sector is trading at $65.49 with a market capitalization of $3.4B. Wall Street consensus targets $61.67 (6 analysts), implying a -5.8% move over the next 12 months. The stock is currently near its 52-week high of $72.51, remaining 114.3% above its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the safe zone. The Whystock Score of 95/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $131.95M↑ | $117.70M↑ | $108.39M↑ | $100.06M↑ | $86.68M |
| Gross Profit | $96.98M↑ | $84.07M↑ | $72.87M↑ | $69.40M↑ | $58.02M |
| Operating Income | $257,000↓ | $1.80M↑ | -$6.04M↓ | -$246,000↑ | -$10.77M |
| Net Income | $110.64M↑ | $2.81M↑ | -$4.11M↓ | $1.68M↑ | -$8.57M |
CareDx, Inc. provides solutions for improving outcomes for transplant patients and advancing organ health in the United States and internationally. The company provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney tra...